ClinConnect ClinConnect Logo
Search / Trial NCT06872229

The Impact of Sensory Integration on Attention in Autism

Launched by ISTITUTO PER LA RICERCA E L'INNOVAZIONE BIOMEDICA · Mar 6, 2025

Trial Information

Current as of April 23, 2025

Recruiting

Keywords

Autism Autism Spectrum Condition Utism Spectrum Disorder Sensory Overload Sensory Processing Sensory Integration

ClinConnect Summary

This clinical trial, titled "The Impact of Sensory Integration on Attention in Autism," is exploring how different ways of presenting sounds and images affect attention and task performance in people with Autism Spectrum Disorder (ASD) compared to those without autism. Researchers want to find out if showing sounds and images at the same time makes it harder for individuals with autism to focus and respond accurately. They believe that separating the sounds and images might help improve their performance. Participants will be asked to complete tasks that involve matching sounds and images while their reaction times and accuracy are measured.

To be eligible for this study, participants need to have a diagnosis of autism and a certain level of cognitive ability. Those with significant hearing or vision problems, other medical conditions, or a history of psychiatric issues will not be included. The trial is currently recruiting participants aged between 14 and 38 years, regardless of gender. Those who take part will experience two different ways of receiving information—simultaneous and separate—and help researchers learn more about how these methods can support better learning and performance for individuals with autism in everyday settings.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of Autism
  • QI ≥ 80
  • Exclusion Criteria:
  • significant hearing or visual impairments
  • presence of other medical disorders
  • history of psychiatric diagnosis

Trial Officials

Flavia Marino

Principal Investigator

Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)

About Istituto Per La Ricerca E L'innovazione Biomedica

Istituto per la Ricerca e l'Innovazione Biomedica (IRIB) is a leading clinical trial sponsor dedicated to advancing biomedical research and innovation. With a focus on enhancing patient outcomes through rigorous scientific investigation, IRIB collaborates with academic institutions, healthcare providers, and industry partners to conduct high-quality clinical trials. The institute is committed to fostering cutting-edge research that addresses unmet medical needs, ensuring compliance with ethical standards and regulatory requirements, and promoting the translation of research findings into clinical practice. Through its expertise and commitment to excellence, IRIB plays a pivotal role in shaping the future of healthcare.

Locations

Messina, Me, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported